T_3、T_4型胃癌根治术后早期腹腔内化疗36例

Observation of Treatment of Intraperitoneal Chemotherapy in Postoperative T_3, T_4 Gastric Cancer

（目的）探讨T3、T4型胃癌根治术后早期腹腔内化疗的疗效。（方法）对36例T3、T4型胃癌病人在根治术后早期行腹腔内化疗，并与同期16例T3、T4胃癌根治术后行传统的静脉化疗相比较。（结果）腹腔内化疗用无明显血毒性反应，对肝肾功能无明显影响，未发生严重并发症，能显著报高胃癌根治术后病人的1年、2年、3年生存率，疗效满意。（结论〕腹腔内化疗简便易行，无严重责副反应和并发症，是T3、T4型胃癌病人术后一项颇有前途的辅助化疗措施。

(Purpose) To investigate the treatment meults of intrapedtoneal chemotherapy(IPC) after radical subtotal gastrectomy on T3,T4 gastric cancer. (Methods) 36 cases with T3,T4 gastric cancer recieved IPC in petoperation, contxasting with 16 cases underwent traditional intravenous cbemotherapy in corresponding period. (Results) There was no serious hernotologic, hepatic or renal toxici-ties and complications in IPC group. IPC can grealy improve the 1,2 and 3 years survival rate. (Concluaions) IPC is a simple and easy adjuvant treatment withou serious toxicities and complications for T3,T4 gastric cancers after operation.